Bioequivalence of a Pediatric Fixed ‐Dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Compared With Coadministration of the Separate Agents in Healthy Adults: An Open‐Label, Randomized, Replicate Crossover Study

In conclusion, administration of D/C/F/TAF 675/150/200/10-mg FDC was bioequivalent to coadministration of the separate commercially available formula tions.

Source: Clinical Pharmacology in Drug Development - June 20, 2023 Category: Drugs & Pharmacology Authors: Sandy Van Hemelryck, Erika Van Landuyt, Jay Ariyawansa, Simon Vanveggel, Martyn Palmer Tags: Original Article Source Type: research